500
Participants
Start Date
July 16, 2023
Primary Completion Date
June 30, 2028
Study Completion Date
Lecanemab
Observational study
RECRUITING
Beth Israel Deaconess Medical Center, Boston
Beth Israel Deaconess Medical Center
OTHER